No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies

No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies

Bibliographic Details
Main Authors: Regine Dahse, Katrin Kromeyer-Hauschild, Alexander Berndt, Hartwig Kosmehl
Format: Article
Language:English
Published: Hindawi Limited 2009-01-01
Series:Journal of Biomedicine and Biotechnology
Online Access:http://dx.doi.org/10.1155/2009/501736
id doaj-dd51a981d5f54223a01e5bba916b476e
record_format Article
spelling doaj-dd51a981d5f54223a01e5bba916b476e2020-11-25T01:04:33ZengHindawi LimitedJournal of Biomedicine and Biotechnology1110-72431110-72512009-01-01200910.1155/2009/501736501736No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR TherapiesRegine Dahse0Katrin Kromeyer-Hauschild1Alexander Berndt2Hartwig Kosmehl3Institute of Pathology, HELIOS Klinikum Erfurt, Nordhauser Str. 74, 99089 Erfurt, GermanyInstitute of Human Genetics and Anthropology, Friedrich Schiller University of Jena, Kollegiengasse 10, 07740 Jena, GermanyInstitute of Pathology, Friedrich Schiller University of Jena, Ziegelmühlenweg, 07740 Jena, GermanyInstitute of Pathology, HELIOS Klinikum Erfurt, Nordhauser Str. 74, 99089 Erfurt, Germanyhttp://dx.doi.org/10.1155/2009/501736
collection DOAJ
language English
format Article
sources DOAJ
author Regine Dahse
Katrin Kromeyer-Hauschild
Alexander Berndt
Hartwig Kosmehl
spellingShingle Regine Dahse
Katrin Kromeyer-Hauschild
Alexander Berndt
Hartwig Kosmehl
No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
Journal of Biomedicine and Biotechnology
author_facet Regine Dahse
Katrin Kromeyer-Hauschild
Alexander Berndt
Hartwig Kosmehl
author_sort Regine Dahse
title No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
title_short No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
title_full No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
title_fullStr No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
title_full_unstemmed No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
title_sort no incidence of braf mutations in salivary gland carcinomas—implications for anti-egfr therapies
publisher Hindawi Limited
series Journal of Biomedicine and Biotechnology
issn 1110-7243
1110-7251
publishDate 2009-01-01
url http://dx.doi.org/10.1155/2009/501736
work_keys_str_mv AT reginedahse noincidenceofbrafmutationsinsalivaryglandcarcinomasimplicationsforantiegfrtherapies
AT katrinkromeyerhauschild noincidenceofbrafmutationsinsalivaryglandcarcinomasimplicationsforantiegfrtherapies
AT alexanderberndt noincidenceofbrafmutationsinsalivaryglandcarcinomasimplicationsforantiegfrtherapies
AT hartwigkosmehl noincidenceofbrafmutationsinsalivaryglandcarcinomasimplicationsforantiegfrtherapies
_version_ 1725197313144520704

Similar Items